Skip to main content

Table 1 Clinico-pathological parameters.

From: Influence of ultra-low dose Aprotinin on thoracic surgical operations: a prospective randomized trial

  

Group A

Group B

Total

Parameters

Age

58.5 ± 9.8

57.5 ± 16.3

58.0 ± 13.2

 

Gender(male/females)

27/3

26/3

53/6

 

BMI*

25.2 ± 3.8

24.8 ± 3.9

25.0 ± 3.8

Diagnosis

Bronchiectasis

1

1

2

 

Bullous disease

3

3

6

 

Diaphragmatic tumors

0

1

1

 

Empyema

4

4

8

 

Esophageal achalasia

1

0

1

 

Lung carcinoma

18

17

35

 

Pulmonary metastases

2

2

4

 

Thymoma

1

1

2

 

Total

30

29

59

Co-morbitidy

COPD

7

6

13

 

Diabetes Mellitus

4

6

10

 

Hypertension

7

9

16

 

Serum Crea: 1.5–2.0 mg/dl

1

1

2

 

Past history of cancer

2

1

3

 

Coronary artery disease

3

3

6

 

Extracardiac arteriopathy

1

1

2

 

WBC's >15,000 mm/cm3

1

0

1

Pathology

Primary lung carcinoma

18

17

35

 

Other organ carcinoma

3

4

7

 

Primary inflammatory disease

5

5

10

 

Other

4

3

7

 

Total

30

29

59

  1. *BMI: Body Mass Index.
  2. COPD = Chronic Obstructive Pulmonary Disease, WBC's = White Blood Count.